Document is current
Any future updates will be listed below
-
Authors
Fredolini, Claudia
Pathak, Khyatiben V.
Paris, Luisa
Chapple, Kristina M.
Tsantilas, Kristine A.
Rosenow, Matthew
Tegeler, Tony J.
Garcia-Mansfield, Krystine
Tamburro, Davide
Zhou, Weidong
Russo, Paul
Massarut, Samuele
Facchiano, Francesco
Belluco, Claudio
De Maria, Ruggero
Garaci, Enrico
Liotta, Lance
Petricoin, Emanuel F.
Pirrotte, Patrick https://orcid.org/0000-0003-1360-6039
-
Funding
Funding for this research was provided by:
Istituto Superiore di SanitÃ
- License Information
-
More Information
Article History
Received: 27 January 2020
Accepted: 16 November 2020
First Online: 2 December 2020
Ethics approval and consent to participate
: The research protocol was approved by the Ethic Committee of each Clinical Center involved, and all patients provided appropriate informed consent.
: All authors approved the manuscript and consented to its publication.
: EFP, AL, and LL are co-inventors on the HN technology owned by George Mason University and might receive royalties as provided by US LAW. EFP, AL, and LL are co-founders of Ceres Nanosciences, Inc. the exclusive licensee to the HN technology, with less than 3% equity ownership interests. EFP and LL act as consultants to the Company.
